InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Miller-Rich Nancy, Director. Insider active across 2 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 6 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €4k. History available since 27 May 2021. The latest transaction was filed on 3 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
413 shares@ US$12.81100.0% of flowCommon StockSEC:0000950170-24-116048:0
Canonical exit: 1 Aug 2021 (T+90)
22,304 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117105:0
8,111 shares0Common StockSEC:0001104659-23-064840:0
7,737 shares0Common StockSEC:0001104659-22-065906:0
7,029 shares0Common StockSEC:0001104659-21-075220
7,029 shares0Common StockSEC:0001104659-21-075220:0
6 of 6 declarations
About Miller-Rich Nancy
Nancy Miller-Rich is a Board Member at INTERCEPT PHARMACEUTICALS, INC. She brings valuable expertise in the pharmaceutical field, actively participating in the governance and strategy of the company. Her role is crucial in guiding the organization through its research and development initiatives.
